US5922340A
(en)
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
ATE288270T1
(de)
|
1993-11-19 |
2005-02-15 |
Janssen Pharmaceutica Nv |
Mikroverkapselte 1,2-benzazole
|
EP2283821A1
(de)
*
|
1993-11-19 |
2011-02-16 |
Alkermes, Inc. |
Herstellung biodegradierbarer Mikroteilchen, die ein biologisch aktives Mittel enthalten
|
US5879712A
(en)
*
|
1995-06-07 |
1999-03-09 |
Sri International |
Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
|
AU706541B2
(en)
|
1995-06-09 |
1999-06-17 |
Euro-Celtique S.A. |
Formulations and methods for providing prolonged local anesthesia
|
WO1997002019A1
(en)
|
1995-06-30 |
1997-01-23 |
Baylor University |
Polyester/carboxylic acid composite materials
|
AU717113B2
(en)
|
1995-11-09 |
2000-03-16 |
Health Protection Agency |
Microencapsulated DNA for vaccination and gene therapy
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
DE19545257A1
(de)
*
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
GB2310801A
(en)
*
|
1996-03-04 |
1997-09-10 |
Merck & Co Inc |
Process for removing an organic solvent from lactide-glycoside copolymer microspheres
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
SI1210942T1
(sl)
*
|
1996-05-07 |
2007-10-31 |
Alkermes Inc |
Mikrodelci
|
TW487572B
(en)
*
|
1996-05-20 |
2002-05-21 |
Janssen Pharmaceutica Nv |
Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
|
EP0954301A4
(de)
*
|
1996-06-24 |
2006-03-08 |
Euro Celtique Sa |
Verfahren zur erzeugung einer sicheren lokalen anästhesie
|
WO1998008095A1
(en)
*
|
1996-08-23 |
1998-02-26 |
Abbott Laboratories |
Procedure for attaching substances to particles
|
US6046187A
(en)
|
1996-09-16 |
2000-04-04 |
Children's Medical Center Corporation |
Formulations and methods for providing prolonged local anesthesia
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US5945126A
(en)
*
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
US7303756B1
(en)
|
1997-06-05 |
2007-12-04 |
Bertex Pharma Gmbh |
Multiphase system
|
US6248345B1
(en)
|
1997-07-02 |
2001-06-19 |
Euro-Celtique, S.A. |
Prolonged anesthesia in joints and body spaces
|
ES2248914T3
(es)
|
1997-08-29 |
2006-03-16 |
Corixa Corporation |
Agentes bioactivos encapsulados de liberacion rapida que permiten inducir o potenciar una respuesta inmunitaria y metodos para utilizar los mismos.
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
GB9810236D0
(en)
*
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
US6451335B1
(en)
|
1998-07-02 |
2002-09-17 |
Euro-Celtique S.A. |
Formulations and methods for providing prolonged local anesthesia
|
US6270802B1
(en)
|
1998-10-28 |
2001-08-07 |
Oakwood Laboratories L.L.C. |
Method and apparatus for formulating microspheres and microcapsules
|
US6194006B1
(en)
*
|
1998-12-30 |
2001-02-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of microparticles having a selected release profile
|
US6498153B1
(en)
*
|
1998-12-31 |
2002-12-24 |
Akzo Nobel N.V. |
Extended release growth promoting two component composition
|
US6204308B1
(en)
|
1999-03-01 |
2001-03-20 |
Novartis Ag |
Organic compounds
|
EP1044683A1
(de)
*
|
1999-04-15 |
2000-10-18 |
Debio Recherche Pharmaceutique S.A. |
Einschrittdispersionsverfahren zur Mikroverkapselung von wasserlöslichen Substanzen
|
US6291013B1
(en)
*
|
1999-05-03 |
2001-09-18 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
DE19925184A1
(de)
*
|
1999-05-26 |
2000-11-30 |
Schering Ag |
Kontinuierliches Verfahren zur Herstellung von morphologisch einheitlichen Mikro- und Nanopartikeln mittels Mikromischer sowie nach diesem Verfahren hergestellte Partikel
|
GB9914412D0
(en)
*
|
1999-06-22 |
1999-08-18 |
Worrall Eric E |
Method for the preservation of viruses,bacteria and biomolecules
|
FR2797784B1
(fr)
*
|
1999-08-27 |
2001-11-30 |
Mainelab |
Procede d'encapsulation de matieres actives par coacervation de polymeres en solvant organique non-chlore
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
US6705757B2
(en)
|
1999-11-12 |
2004-03-16 |
Alkermes Controlled Therapeutics, Inc. Ii |
Method and apparatus for preparing microparticles using in-line solvent extraction
|
US6331317B1
(en)
|
1999-11-12 |
2001-12-18 |
Alkermes Controlled Therapeutics Ii Inc. |
Apparatus and method for preparing microparticles
|
US6495166B1
(en)
|
1999-11-12 |
2002-12-17 |
Alkermes Controlled Therapeutics Inc. |
Apparatus and method for preparing microparticles using in-line solvent extraction
|
WO2001051024A2
(de)
|
2000-01-11 |
2001-07-19 |
Roland Bodmeier |
Kit zur implantation enthaltend eine trägerphase und ein lösemittel
|
DK1255547T3
(da)
|
2000-02-08 |
2008-12-01 |
Euro Celtique Sa |
Kontrolleret-frigivelsessammensætninger indeholdende opioid-agonist og antagonist
|
GB0008411D0
(en)
*
|
2000-04-05 |
2000-05-24 |
Vectura Ltd |
Pharmaceutical preparations and their manufacture
|
AR023940A1
(es)
*
|
2000-05-03 |
2002-09-04 |
Eriochem Sa |
Procedimiento para la produccion de microcapsulas de liberacion prolongada de peptidos solubles en agua
|
US6264987B1
(en)
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
EP1289512B1
(de)
*
|
2000-05-24 |
2005-03-09 |
Jordan L. Holtzman |
Mittel und verfahren zur erhöhung des chaperonin-spiegels im gehirn
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
US6467949B1
(en)
*
|
2000-08-02 |
2002-10-22 |
Chemineer, Inc. |
Static mixer element and method for mixing two fluids
|
US6362308B1
(en)
*
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
DE60140625D1
(de)
|
2000-08-15 |
2010-01-07 |
Univ Illinois |
Verfahren zur herstellung von mikropartikeln
|
DE10044545A1
(de)
*
|
2000-09-05 |
2002-04-04 |
Roland Bodmeier |
Retardpartikeldispersion
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US6482440B2
(en)
|
2000-09-21 |
2002-11-19 |
Phase 2 Discovery, Inc. |
Long acting antidepressant microparticles
|
US6471995B1
(en)
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
US7666445B2
(en)
*
|
2000-10-20 |
2010-02-23 |
The Trustees Of The University Of Pennsylvania |
Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
|
DE60138641D1
(de)
|
2000-10-27 |
2009-06-18 |
Baxter Healthcare Sa |
Herstellung von mikrokügelchen
|
US20020114843A1
(en)
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
WO2002058670A1
(en)
*
|
2001-01-25 |
2002-08-01 |
Euroceltique S.A. |
Local anesthetic, and method of use
|
EP1365770A2
(de)
*
|
2001-02-07 |
2003-12-03 |
Durect Corporation |
Vorrichtungen und verfahren zur erhaltung der knochendichte
|
US6730772B2
(en)
|
2001-06-22 |
2004-05-04 |
Venkatram P. Shastri |
Degradable polymers from derivatized ring-opened epoxides
|
US20080026068A1
(en)
*
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
EP1418890B1
(de)
*
|
2001-08-16 |
2008-05-14 |
Baxter International Inc. |
Darreichungsformen welche mikropartikel und treibgas enthalten
|
US20030170289A1
(en)
*
|
2001-11-14 |
2003-09-11 |
Guohua Chen |
Injectable depot compositions and uses thereof
|
KR20040058101A
(ko)
*
|
2001-11-14 |
2004-07-03 |
알자 코포레이션 |
카테터 주입가능한 데포 조성물 및 그의 용도
|
US20050152980A1
(en)
|
2002-03-13 |
2005-07-14 |
Michael Ausborn |
Pharmeutical microparticles
|
ES2665999T3
(es)
*
|
2002-05-31 |
2018-04-30 |
Titan Pharmaceuticals, Inc. |
Dispositivo polimérico implantable para la liberación sostenida de buprenorfina
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
US7838034B2
(en)
*
|
2002-07-30 |
2010-11-23 |
Grunenthal Gmbh |
Intravenous pharmaceutical form of administration
|
CN1668276A
(zh)
*
|
2002-07-31 |
2005-09-14 |
阿尔萨公司 |
可注射的储库组合物及其用途
|
CN1694689A
(zh)
*
|
2002-09-30 |
2005-11-09 |
阿库斯菲尔公司 |
供吸入的缓释多孔微粒
|
WO2004035623A2
(en)
*
|
2002-10-02 |
2004-04-29 |
Zealand Pharma A/S |
Stabilized exendin-4 compounds
|
US20040071847A1
(en)
*
|
2002-10-15 |
2004-04-15 |
Cargill, Inc. |
Producing cocoa powders with different cocoa butter contents by liquefied gas extraction on substantially the same production line
|
US20040071848A1
(en)
*
|
2002-10-15 |
2004-04-15 |
Cargill Inc. |
Process for producing cocoa butter and cocoa powder by liquefied gas extraction
|
US6800663B2
(en)
*
|
2002-10-18 |
2004-10-05 |
Alkermes Controlled Therapeutics Inc. Ii, |
Crosslinked hydrogel copolymers
|
CA2504608C
(en)
|
2002-11-06 |
2013-01-08 |
Alza Corporation |
Controlled release depot formulations
|
MXPA05010450A
(es)
*
|
2003-03-31 |
2005-11-04 |
Titan Pharmaceuticals Inc |
Dispositivo polimerico implantable para la liberacion prolongada de agonistas de dopamina.
|
ES2427092T3
(es)
*
|
2003-04-10 |
2013-10-28 |
Evonik Corporation |
Un método para la producción de micropartículas a base de emulsión
|
US20070207211A1
(en)
*
|
2003-04-10 |
2007-09-06 |
Pr Pharmaceuticals, Inc. |
Emulsion-based microparticles and methods for the production thereof
|
JP4547995B2
(ja)
*
|
2003-06-03 |
2010-09-22 |
参天製薬株式会社 |
微粒子の製造法
|
JP2007526217A
(ja)
*
|
2003-06-04 |
2007-09-13 |
アルカーメス,インコーポレイテッド |
ナルトレキソンの多型形態
|
WO2005009356A2
(en)
*
|
2003-07-15 |
2005-02-03 |
Pr Pharmaceuticals, Inc. |
Method for the preparation of controlled release formulations
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
CA2532837A1
(en)
*
|
2003-07-18 |
2005-04-21 |
Baxter International, Inc. |
Method for preparing small spherical particles by controlled phase separation
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
JP2007508240A
(ja)
*
|
2003-07-22 |
2007-04-05 |
バクスター・インターナショナル・インコーポレイテッド |
低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
|
CN100588423C
(zh)
|
2003-07-23 |
2010-02-10 |
Pr药品有限公司 |
控释组合物
|
US20050031713A1
(en)
*
|
2003-08-06 |
2005-02-10 |
Elliot Ehrich |
Methods for administering active agents to CYP3A4 sensitive patients
|
US6987111B2
(en)
*
|
2003-08-06 |
2006-01-17 |
Alkermes Controlled Therapeutics, Ii |
Aripiprazole, olanzapine and haloperidol pamoate salts
|
JP2007533634A
(ja)
*
|
2003-09-30 |
2007-11-22 |
アキュスフィア, インコーポレイテッド |
注射、経口、または局所用の徐放性医薬製剤
|
US7309500B2
(en)
*
|
2003-12-04 |
2007-12-18 |
The Board Of Trustees Of The University Of Illinois |
Microparticles
|
US8221778B2
(en)
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
JP5306599B2
(ja)
*
|
2004-01-12 |
2013-10-02 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
長期間送達製剤
|
US8329203B2
(en)
*
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
US20050245461A1
(en)
*
|
2004-03-19 |
2005-11-03 |
Elliot Ehrich |
Methods for treating alcoholism
|
US20050245541A1
(en)
*
|
2004-03-19 |
2005-11-03 |
Elliot Ehrich |
Methods for treating alcoholism
|
SI2409707T1
(sl)
|
2004-04-15 |
2015-07-31 |
Alkermes Pharma Ireland Limited |
Naprava s podaljšanim sproščanjem na osnovi polimerov
|
US7919499B2
(en)
|
2004-04-22 |
2011-04-05 |
Alkermes, Inc. |
Naltrexone long acting formulations and methods of use
|
US20050260272A1
(en)
*
|
2004-05-05 |
2005-11-24 |
Alkermes Controlled Therapeutics, Inc. |
Method of forming microparticles that include a bisphosphonate and a polymer
|
MXPA06012989A
(es)
*
|
2004-05-12 |
2007-06-12 |
Baxter Int |
Microesferas de acidos nucleicos, produccion y suministro de las mismas.
|
EP1753404A1
(de)
|
2004-05-12 |
2007-02-21 |
Baxter International Inc. |
Mikrokügelchen mit protein; die bei hohen konzentrationen des mittels injizierbar sind
|
US8728525B2
(en)
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
EP2335689A1
(de)
*
|
2004-05-12 |
2011-06-22 |
Baxter International Inc. |
Herstellungsmethode von Nukleinsäure-Mikrokügelchen
|
US20060253100A1
(en)
|
2004-10-22 |
2006-11-09 |
Medtronic, Inc. |
Systems and Methods to Treat Pain Locally
|
US7748343B2
(en)
|
2004-11-22 |
2010-07-06 |
The Board Of Trustees Of The University Of Illinois |
Electrohydrodynamic spraying system
|
US20080213593A1
(en)
*
|
2005-01-21 |
2008-09-04 |
President And Fellows Of Harvard College |
Systems And Methods For Forming Fluidic Droplets Encapsulated In Particles Such As Colloidal Particles
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
WO2006116546A1
(en)
*
|
2005-04-27 |
2006-11-02 |
Baxter International Inc. |
Surface-modified microparticles and methods of forming and using the same
|
ATE550031T1
(de)
|
2005-06-06 |
2012-04-15 |
Univ Georgetown |
Zusammensetzungen und verfahren für die lipomodellierung
|
GB0516549D0
(en)
*
|
2005-08-12 |
2005-09-21 |
Sulaiman Brian |
Milling system
|
WO2007024700A2
(en)
|
2005-08-19 |
2007-03-01 |
Amylin Pharmaceuticals, Inc. |
Exendin for treating diabetes and reducing body weight
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
US7669732B2
(en)
*
|
2005-10-25 |
2010-03-02 |
Imi Cornelius Inc. |
Cup lid dispenser
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US20070099947A1
(en)
*
|
2005-11-03 |
2007-05-03 |
Alkermes, Inc. |
Methods and compositions for the treatment of brain reward system disorders by combination therapy
|
CA2631493A1
(en)
*
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
EP1978933A2
(de)
*
|
2005-12-15 |
2008-10-15 |
Acusphere, Inc. |
Verfahren zur herstellung von pharmazeutischen formulierungen auf teilchenbasis zur oralen verabreichung
|
US8182134B2
(en)
*
|
2005-12-16 |
2012-05-22 |
PRC De Soto International, Inc. |
Mixing system for thermoset compositions including static and rotary mixers
|
US7600911B2
(en)
*
|
2006-01-13 |
2009-10-13 |
Bechtold Gerald L |
Water-mixing device, sand trap and method of using same
|
US20070281031A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Guohan Yang |
Microparticles and methods for production thereof
|
US20080015546A1
(en)
*
|
2006-07-13 |
2008-01-17 |
Casas Jesus W |
Methods and formulations for optimal local delivery of cell therapy via minimally invasive procedures
|
CN105168146A
(zh)
*
|
2006-08-04 |
2015-12-23 |
巴克斯特国际公司 |
预防和/或逆转新发作自身免疫糖尿病的基于微球的组合物
|
DK2359808T3
(da)
|
2006-08-09 |
2013-08-05 |
Intarcia Therapeutics Inc |
Osmotiske leveringssystemer og stempelaggregater
|
JP2010505882A
(ja)
*
|
2006-10-06 |
2010-02-25 |
バクスター・インターナショナル・インコーポレイテッド |
表面改質微粒子を含むマイクロエンカプセルならびに、その形成および使用の方法
|
US20080098900A1
(en)
*
|
2006-11-01 |
2008-05-01 |
Babatunde Aremu |
Beverage manufacture using a static mixer
|
AU2008231093A1
(en)
*
|
2007-03-22 |
2008-10-02 |
Alkermes, Inc. |
Coacervation process
|
MX2009011123A
(es)
|
2007-04-23 |
2009-11-02 |
Intarcia Therapeutics Inc |
Formulaciones de suspensiones de peptidos insulinotropicos y sus usos.
|
CN100548278C
(zh)
*
|
2007-05-17 |
2009-10-14 |
中国人民解放军军事医学科学院生物工程研究所 |
一种提高纳曲酮微球包封率的制备方法
|
DK2167039T3
(en)
|
2007-05-18 |
2017-01-09 |
Durect Corp |
Improved depot formulations
|
BRPI0811319A2
(pt)
|
2007-05-25 |
2015-02-10 |
Tolmar Therapeutics Inc |
Composição fluida, método de formação de uma composição fluida, implante biodegrádavel formado in situ, método de formação de um implante biodegradável in situ, kit, implante e método de trataento
|
US20080317865A1
(en)
*
|
2007-06-20 |
2008-12-25 |
Alkermes, Inc. |
Quench liquids and washing systems for production of microparticles
|
BRPI0813274A2
(pt)
*
|
2007-06-25 |
2014-12-30 |
Otsuka Pharma Co Ltd |
Microesferas tendo estrutura de núcleo/revestimento
|
FR2918296B1
(fr)
*
|
2007-07-05 |
2009-09-18 |
Oreal |
Capsules de type noyau/ecorce et procede de preparation
|
ES2639016T3
(es)
|
2007-11-16 |
2017-10-25 |
The Rockefeller University |
Anticuerpos específicos para la forma protofibrilar de proteína beta-amiloide
|
EP2222284B1
(de)
*
|
2007-11-19 |
2020-07-01 |
Capsulated Systems Inc. |
Verlängerte freisetzung von lokalanästhetika mit mikropartikeln und operative anwendungen
|
US8728528B2
(en)
|
2007-12-20 |
2014-05-20 |
Evonik Corporation |
Process for preparing microparticles having a low residual solvent volume
|
CA2726861C
(en)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
EP2259677A4
(de)
*
|
2008-02-29 |
2011-11-02 |
Alseres Pharmaceuticals Inc |
Systemische purinverabreichung zur modulation des axonalen wachstums des zentralnervensystems
|
WO2009158724A2
(en)
|
2008-06-27 |
2009-12-30 |
Tepha, Inc. |
Improved injectable delivery of microparticles and compositions therefore
|
US8323685B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US8323615B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
US8367427B2
(en)
*
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US20100047292A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Baxter International Inc. |
Methods of processing microparticles and compositions produced thereby
|
US20100087337A1
(en)
|
2008-09-10 |
2010-04-08 |
Bind Biosciences, Inc. |
High Throughput Fabrication of Nanoparticles
|
JP5757872B2
(ja)
*
|
2008-09-11 |
2015-08-05 |
エボニック コーポレイションEvonik Corporation |
調整可能な抽出速度を有する溶媒抽出マイクロカプセル化
|
LT2349324T
(lt)
|
2008-10-17 |
2017-12-27 |
Sanofi-Aventis Deutschland Gmbh |
Insulino ir glp-1 agonisto derinys
|
US20110224312A1
(en)
*
|
2008-11-17 |
2011-09-15 |
Wayne State University |
Engineering porous particles of water soluble therapeutics for pressurized metered-dose inhaler formulations
|
US20100189800A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Peter Markland |
Continous double emulsion process for making microparticles
|
US20100196436A1
(en)
*
|
2009-01-30 |
2010-08-05 |
Gooberman Lance L |
Implants containing disulfiram and an anti-inflammatory agent
|
US8791093B2
(en)
*
|
2009-05-29 |
2014-07-29 |
Lance L. Gooberman |
Pharmaceutical delivery systems for treatment of substance abuse and other addictions
|
ES2650667T3
(es)
|
2009-09-28 |
2018-01-19 |
Intarcia Therapeutics, Inc |
Rápido establecimiento y/o terminación de la administración sustancial de fármaco en estado estacionario
|
ES2855146T3
(es)
|
2009-11-13 |
2021-09-23 |
Sanofi Aventis Deutschland |
Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
|
TWI468171B
(zh)
|
2009-11-13 |
2015-01-11 |
Sanofi Aventis Deutschland |
含glp-1激動劑及甲硫胺酸之醫藥組成物
|
JP5839362B2
(ja)
*
|
2010-03-02 |
2016-01-06 |
ファーベント ファーマスーティカルズ, エルエルシーFervent Pharmaceuticals, Llc |
ホルモン変動の症状を治療または予防するための方法および組成物
|
US8461102B2
(en)
|
2010-03-02 |
2013-06-11 |
George E. Royster, JR. |
Methods and compositions for treating and preventing symptoms of hormonal variations
|
US8207290B2
(en)
|
2010-03-26 |
2012-06-26 |
Cerulean Pharma Inc. |
Methods and systems for generating nanoparticles
|
UA111162C2
(uk)
|
2010-08-04 |
2016-04-11 |
Флекшен Терап'Ютікс, Інк. |
Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
|
LT2608670T
(lt)
|
2010-08-23 |
2019-01-25 |
Alkermes Pharma Ireland Limited |
Antipsichotikų sukelto padidėjusio svorio sumažinimo būdai
|
CN103179978A
(zh)
|
2010-08-30 |
2013-06-26 |
赛诺菲-安万特德国有限公司 |
Ave0010用于制造供治疗2型糖尿病用的药物的用途
|
JP6343147B2
(ja)
|
2010-08-30 |
2018-06-13 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
狭窄病変および血栓溶解療法のための剪断による制御放出
|
US8546521B2
(en)
|
2011-01-28 |
2013-10-01 |
Cerulean Pharma Inc. |
Method for fabricating nanoparticles
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
ES2642312T3
(es)
|
2011-08-04 |
2017-11-16 |
Flexion Therapeutics, Inc. |
Corticosteroides para el tratamiento del dolor de articulaciones
|
JP6367115B2
(ja)
|
2011-08-29 |
2018-08-01 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
2型糖尿病患者の血糖コントロールに使用する組合せ医薬
|
AR087744A1
(es)
|
2011-09-01 |
2014-04-16 |
Sanofi Aventis Deutschland |
Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
|
US10357496B2
(en)
|
2011-11-05 |
2019-07-23 |
South Alabama Medical Science Foundation |
Methods, formulations, and kits for rapidly repleting folate levels in women
|
EP2934562A1
(de)
|
2012-08-14 |
2015-10-28 |
Wockhardt Limited |
Mikropartikuläre pharmazeutische zusammensetzungen aus polypeptiden
|
EP2931300A1
(de)
|
2012-08-14 |
2015-10-21 |
Wockhardt Limited |
Mikropartikuläre pharmazeutische zusammensetzungen aus polypeptiden
|
WO2014106267A1
(en)
*
|
2012-12-31 |
2014-07-03 |
Bacterin International, Inc. |
Composition of d-alpha hydroxy acids and antimicrobials
|
TWI641381B
(zh)
|
2013-02-04 |
2018-11-21 |
法商賽諾菲公司 |
胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
|
US20140308352A1
(en)
|
2013-03-11 |
2014-10-16 |
Zogenix Inc. |
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
|
US9737605B2
(en)
|
2013-03-11 |
2017-08-22 |
Durect Corporation |
Injectable controlled release composition comprising high viscosity liquid carrier
|
CA2931547A1
(en)
|
2013-12-09 |
2015-06-18 |
Durect Corporation |
Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
|
RU2016132386A
(ru)
|
2014-01-09 |
2018-02-14 |
Санофи |
Стабилизированные фармацевтические составы без глицерина на основе инсулиновых аналогов и/или инсулиновых производных
|
RU2016132340A
(ru)
|
2014-01-09 |
2018-02-14 |
Санофи |
Стабилизированные фармацевтические составы на основе инсулина аспарта
|
AU2015205624A1
(en)
|
2014-01-09 |
2016-07-14 |
Sanofi |
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
|
WO2015150942A2
(en)
|
2014-03-29 |
2015-10-08 |
The WOCKHARDT LIMITED |
Improved process for preparing microparticles
|
US9439864B2
(en)
*
|
2014-07-07 |
2016-09-13 |
Antriabio, Inc. |
Solvent extraction from biodegradable microparticles
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
CR20170314A
(es)
|
2014-12-12 |
2017-10-20 |
Sanofi Aventis Deutschland |
Formulación de relación fija de insulina glargina/lixisenatida
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患治療
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患之治療
|
MA44390A
(fr)
|
2015-06-03 |
2019-01-23 |
Intarcia Therapeutics Inc |
Systèmes de mise en place et de retrait d'implant
|
EP3348268A4
(de)
*
|
2015-09-07 |
2019-04-10 |
Nipro Corporation |
Risperidonhaltige mikrokapsel, verfahren zur herstellung davon und freisetzungssteuerungsverfahren
|
JP2017071740A
(ja)
*
|
2015-10-09 |
2017-04-13 |
信越化学工業株式会社 |
球状ポリオルガノシルセスキオキサン粒子の製造方法
|
BR112018016226A8
(pt)
|
2016-02-10 |
2023-10-24 |
Univ Rutgers |
Anticorpo antilipoarabinomanana (anti-lam) monoclonal humano, kit para detectar pelo menos um epítopo de lam, método para diagnosticar uma infecção de tuberculose ativa em um indivíduo, método para tratar uma infecção de tuberculose em um indivíduo, anticorpo monoclonal humano anti-lam e método de pré-concentração de lam a partir de uma amostra biológica
|
US20170258815A1
(en)
|
2016-03-14 |
2017-09-14 |
Flexion Therapeutics, Inc. |
Corticosteroid formulations and methods for the treatment of joint pain in patients with diabetes
|
WO2017200943A1
(en)
|
2016-05-16 |
2017-11-23 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
WO2017199123A1
(en)
|
2016-05-17 |
2017-11-23 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Device and methods for shell phase removal of core-shell capsules
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
WO2018044970A1
(en)
|
2016-08-31 |
2018-03-08 |
University Of Rochester |
Human monoclonal antibodies to human endogenous retrovirus k envelope (herv-k) and uses thereof
|
US10835580B2
(en)
|
2017-01-03 |
2020-11-17 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
KR102142026B1
(ko)
*
|
2017-05-31 |
2020-08-06 |
주식회사 대웅제약 |
방출제어가 용이한 서방성 약물 미립자의 제조방법
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|